Literature DB >> 14968125

Recurrent perivascular inflammation induced by lipopolysaccharide (endotoxin) results in the formation of atheromatous lesions in vivo.

Markus Georg Engelmann1, Constanze Veronika Redl, Sigrid Nikol.   

Abstract

Bacteria and viruses are suspected to induce arteriosclerosis; however, most investigators have focused on coincidences rather than causal relationships. The aim of this work was to establish a rabbit model in which the vessel reaction to local perivascular injection of defined bacterial products can be analyzed. A total of 23 rabbits were randomized to four groups. Groups A and B were fed a normal diet, groups C and D were fed a cholesterol-enriched diet. Groups A and C were treated with a single perivascular injection of bacterial lipopolysaccharide (LPS, endotoxin) placed next to auricular, carotid and femoral arteries, and sodium chloride placed next to the contralateral arteries (control). Group B and D animals were treated with repeated perivascular injections over 90 days. Vascular tissues (n=116 treated segments of 23 rabbits) were analyzed using morphometry at histology, and using immunohistochemistry to detect macrophages, lymphocytes and vascular smooth muscle cells. LPS treatment resulted in transient focal intima thickening. After single LPS application, no increase in atheromatous lesion formation was observed in comparison with controls (group C, lesion area index 0.031+/-0.012 vs 0.015+/-0.006, P=1.0). Repeated LPS application resulted in significant atheromatous lesion formation compared with saline control (group D, lesion area index 0.148+/-0.049 vs 0.008+/-0.006, P=0.003) in hypercholesterolemic rabbits. Repeated LPS inflammation in normocholesterolemic did not lead to atheromatous lesion formation (intima media ratio 0.04+/-0.01 vs 0.04+/-0.007, P=1.0). Single perivascular administration of low-dose bacterial LPS resulted in transient focal intimal thickening, while significant increase in lesion formation occurred after repeated LPS application in cholesterol-fed animals. In conclusion, this animal model will allow the assessment of the impact of defined dosages of different bacterial pathogens onto the vascular wall in the context of atherogenesis. The atheromatous lesion-promoting effect of repeated perivascular administration of LPS supports the hypothesis that bacterial pathogens may be involved in atherogenesis.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14968125     DOI: 10.1038/labinvest.3700065

Source DB:  PubMed          Journal:  Lab Invest        ISSN: 0023-6837            Impact factor:   5.662


  10 in total

1.  Lipopolysaccharide-induced proliferation of the vasa vasorum in a rabbit model of atherosclerosis as evaluated by contrast-enhanced ultrasound imaging and histology.

Authors:  Jinwei Tian; Sining Hu; Xue Han; Nana Dong; Huai Yu; Yanli Sun; Bo Yu
Journal:  Inflammation       Date:  2012-08       Impact factor: 4.092

2.  CD14 is a key mediator of both lysophosphatidic acid and lipopolysaccharide induction of foam cell formation.

Authors:  Dong An; Feng Hao; Fuqiang Zhang; Wei Kong; Jerold Chun; Xuemin Xu; Mei-Zhen Cui
Journal:  J Biol Chem       Date:  2017-07-13       Impact factor: 5.157

3.  5,2'-Dibromo-2,4',5'-trihydroxydiphenylmethanone Inhibits LPS-Induced Vascular Inflammation by Targeting the Cav1 Protein.

Authors:  Hongxia Yuan; Qianyi Hou; Xiue Feng; Yuanlin Zhang; Fan Yang; Rui Ge; Qingshan Li
Journal:  Molecules       Date:  2022-04-30       Impact factor: 4.927

4.  A Novel ASK Inhibitor AGI-1067 Inhibits TLR-4-Mediated Activation of ASK1 by Preventing Dissociation of Thioredoxin from ASK1.

Authors:  Shuhui Zheng; Lingli Long; Yonghao Li; Yuxia Xu; Zhang Jiqin; Weidong Ji; Wang Min
Journal:  Cardiovasc Pharm Open Access       Date:  2015-02-26

5.  Carotid artery brain aneurysm model: in vivo molecular enzyme-specific MR imaging of active inflammation in a pilot study.

Authors:  Michael J DeLeo; Matthew J Gounis; Bo Hong; John C Ford; Ajay K Wakhloo; Alexei A Bogdanov
Journal:  Radiology       Date:  2009-06-22       Impact factor: 11.105

Review 6.  Translational mini-review series on immunology of vascular disease: inflammation, infections and Toll-like receptors in cardiovascular disease.

Authors:  J R Ward; H L Wilson; S E Francis; D C Crossman; I Sabroe
Journal:  Clin Exp Immunol       Date:  2009-03-20       Impact factor: 4.330

7.  JNK1 Mediates Lipopolysaccharide-Induced CD14 and SR-AI Expression and Macrophage Foam Cell Formation.

Authors:  Dong An; Feng Hao; Chen Hu; Wei Kong; Xuemin Xu; Mei-Zhen Cui
Journal:  Front Physiol       Date:  2018-01-05       Impact factor: 4.566

8.  N-Docosahexaenoylethanolamine Attenuates Neuroinflammation and Improves Hippocampal Neurogenesis in Rats with Sciatic Nerve Chronic Constriction Injury.

Authors:  Anna A Tyrtyshnaia; Evgenia L Egorova; Anna A Starinets; Arina I Ponomarenko; Ekaterina V Ermolenko; Igor V Manzhulo
Journal:  Mar Drugs       Date:  2020-10-15       Impact factor: 5.118

9.  5,2'-dibromo-2,4',5'-trihydroxydiphenylmethanone attenuates LPS-induced inflammation and ROS production in EA.hy926 cells via HMBOX1 induction.

Authors:  Hong-Xia Yuan; Xiu-E Feng; En-Li Liu; Rui Ge; Yuan-Lin Zhang; Bao-Guo Xiao; Qing-Shan Li
Journal:  J Cell Mol Med       Date:  2018-10-24       Impact factor: 5.310

10.  Expression of Nik-related kinase in smooth muscle cells attenuates vascular inflammation and intimal hyperplasia.

Authors:  Yi-Jhu Lu; Yee-Jee Jan; Bor-Sheng Ko; Shu-Man Liang; Lujen Chen; Chih-Cheng Wu; Chih-Hui Chin; Cheng-Chin Kuo; Shaw-Fang Yet; Jun-Yang Liou
Journal:  Aging (Albany NY)       Date:  2020-04-24       Impact factor: 5.682

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.